131 related articles for article (PubMed ID: 24137391)
1. Antitumor effects of
Sun L; Zhu X; Xu L; Wang Z; Shao G; Zhao J
Oncol Lett; 2013 Sep; 6(3):687-692. PubMed ID: 24137391
[TBL] [Abstract][Full Text] [Related]
2. ³²P-chromic phosphate-Poly(L-Lactide) seeds of sustained release and their brachytherapy for prostate cancer with lymphatic metastasis.
He X; Jia R; Xu L; Liang K; Wang Z; Shao G; Huang P; Li W
Cancer Biother Radiopharm; 2012 Sep; 27(7):446-51. PubMed ID: 22834706
[TBL] [Abstract][Full Text] [Related]
3. [Implantation brachytherapy with 32P-chromic phosphate-poly (L-lactide) delayed-release particles for prostate cancer in nude mice].
He XJ; Jia RP; Shao GQ; Xu LW; Wang ZZ; Huang PL; Wu JP; Wang J
Zhonghua Nan Ke Xue; 2010 Oct; 16(10):872-6. PubMed ID: 21243748
[TBL] [Abstract][Full Text] [Related]
4. [Experimental study of CT guided ³²P-CP-PLLA microparticle implantation in the treatment of rabbit VX2 lung tumor].
Pan D; Yang M; Xu Y; Wang L; Liu L; Huang P
Zhongguo Fei Ai Za Zhi; 2011 Jan; 14(1):1-6. PubMed ID: 21219823
[TBL] [Abstract][Full Text] [Related]
5. Intratumoral injection of 32P-chromic phosphate in the treatment of implanted pancreatic carcinoma.
Gao W; Liu L; Liu ZY; Wang Y; Jiang B; Liu XN
Cancer Biother Radiopharm; 2010 Apr; 25(2):215-24. PubMed ID: 20423235
[TBL] [Abstract][Full Text] [Related]
6. Investigation of Newly Prepared Biodegradable
Shao G; Wang Y; Liu X; Zhao M; Song J; Huang P; Wang F; Wang Z
Contrast Media Mol Imaging; 2018; 2018():2630480. PubMed ID: 29853804
[No Abstract] [Full Text] [Related]
7. Bioevaluation study of 32P-CP-PLLA particle brachytherapy in a rabbit VX2 lung tumor model.
Xu Yp; Yang M; Pan Dh; Wang Lz; Liu L; Huang P; Shao G
Appl Radiat Isot; 2012 Apr; 70(4):583-8. PubMed ID: 22245365
[TBL] [Abstract][Full Text] [Related]
8. Safety evaluation of 32P-chromic phosphate-poly L lactic acid particles interstitially implanted into livers of Beagle dogs.
Liu L; Huang P; Nie Q; Qi B; Wu Q; Gao H; Yang Z; Chen D
Cancer Biother Radiopharm; 2012 Mar; 27(2):156-63. PubMed ID: 22316174
[TBL] [Abstract][Full Text] [Related]
9. Preliminary study of the biodegradation and the correlation between in vitro and in vivo release of (32)P-chromic phosphate-poly(L-lactide) seeds.
Zhao J; Du G; Su Y; Shao G; Wang Z; Xu L
Cancer Biother Radiopharm; 2013 Dec; 28(10):703-8. PubMed ID: 23806021
[TBL] [Abstract][Full Text] [Related]
10. Enhanced tumor targeting by an intratumoral injection of colloidal chromic 32P in two human tumors (AsPC-1 pancreas and Ls174T colon) in nude mice.
Lee I
J Surg Oncol; 1999 Mar; 70(3):161-6. PubMed ID: 10102345
[TBL] [Abstract][Full Text] [Related]
11. Chromic-P32 phosphate treatment of implanted pancreatic carcinoma: mechanism involved.
Liu L; Feng GS; Gao H; Tong GS; Wang Y; Gao W; Huang Y; Li C
World J Gastroenterol; 2005 Apr; 11(14):2101-8. PubMed ID: 15810075
[TBL] [Abstract][Full Text] [Related]
12. The effect of various therapeutic solutions including colloidal chromic 32P via an intratumoral injection on the tumor physiological parameters of AsPC-1 human pancreatic tumor xenografts in nude mice.
Lee I; Lee YH
Clin Cancer Res; 1999 Oct; 5(10 Suppl):3139s-3142s. PubMed ID: 10541354
[TBL] [Abstract][Full Text] [Related]
13. Novel lactoferrin-conjugated amphiphilic poly(aminoethyl ethylene phosphate)/poly(L-lactide) copolymer nanobubbles for tumor-targeting ultrasonic imaging.
Luo B; Liang H; Zhang S; Qin X; Liu X; Liu W; Zeng F; Wu Y; Yang X
Int J Nanomedicine; 2015; 10():5805-17. PubMed ID: 26396514
[TBL] [Abstract][Full Text] [Related]
14. Tumor-targeted paclitaxel-loaded folate conjugated poly(ethylene glycol)-poly(L-lactide) microparticles produced by supercritical fluid technology.
Huang X; Zhang Y; Yin G; Pu X; Liao X; Huang Z; Chen X; Yao Y
J Mater Sci Mater Med; 2015 Feb; 26(2):95. PubMed ID: 25649516
[TBL] [Abstract][Full Text] [Related]
15. Structure, morphology and cell affinity of poly(L-lactide) films surface-functionalized with chitosan nanofibers via a solid-liquid phase separation technique.
Zhao J; Han W; Tang M; Tu M; Zeng R; Liang Z; Zhou C
Mater Sci Eng C Mater Biol Appl; 2013 Apr; 33(3):1546-53. PubMed ID: 23827607
[TBL] [Abstract][Full Text] [Related]
16. [Anti-tumor effect of eukaryotic expressing plasmid containing soluble tumor necrotic factor-related apoptosis inducing ligand combined with human angiostatin Kringle (1 - 3) genes on human gastric cancer xenografts in nude mice].
Sun W; Jiang Z; Xiang TX; Tao XH; Huang AL; Wang PL
Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(12):841-5. PubMed ID: 19595126
[TBL] [Abstract][Full Text] [Related]
17. Enzymatic hydrolysis of poly(lactide)s: effects of molecular weight, L-lactide content, and enantiomeric and diastereoisomeric polymer blending.
Tsuji H; Miyauchi S
Biomacromolecules; 2001; 2(2):597-604. PubMed ID: 11749226
[TBL] [Abstract][Full Text] [Related]
18. Crystallization and Alkaline Degradation Behaviors of Poly(l-Lactide)/4-Armed Poly(ε-Caprolactone)-Block-Poly(d-Lactide) Blends with Different Poly(d-Lactide) Block Lengths.
Dai S; Wang M; Zhuang Z; Ning Z
Polymers (Basel); 2020 Sep; 12(10):. PubMed ID: 32992889
[TBL] [Abstract][Full Text] [Related]
19. Bone Regeneration Capacity of Newly Developed Uncalcined/Unsintered Hydroxyapatite and Poly-l-lactide-co-glycolide Sheet in Maxillofacial Surgery: An In Vivo Study.
Ngo HX; Dong QN; Bai Y; Sha J; Ishizuka S; Okui T; Sukegawa S; Kanno T
Nanomaterials (Basel); 2020 Dec; 11(1):. PubMed ID: 33374294
[TBL] [Abstract][Full Text] [Related]
20. Syntheses and physical characterization of new aliphatic triblock poly(L-lactide-b-butylene succinate-b-L-lactide)s bearing soft and hard biodegradable building blocks.
Ba C; Yang J; Hao Q; Liu X; Cao A
Biomacromolecules; 2003; 4(6):1827-34. PubMed ID: 14606915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
